Avion Wealth’s Adicet Bio ACET Stock Holding History

Avion Wealth’s Portfolio ACET Stock Details ACET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Hold	246	–	–	﹤0.01%	1016
2026 Q1	$1K	Buy	+246	New	+$1.84K	﹤0.01%	949

Other funds holding ACET

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Avion Wealth's ACET Position: Q2 2026 in Review

Avion Wealth held its Adicet Bio (ACET) position steady in Q2 2026 at 246 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Avion Wealth first reported a position in ACET in Q1 2026 and has held it in 2 quarters since. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

Avion Wealth held 246 shares of Adicet Bio worth $2K as of Q2 2026.
Avion Wealth left its Adicet Bio share count unchanged in Q2 2026.
Adicet Bio made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1016 holding.
Avion Wealth first reported a position in Adicet Bio in Q1 2026 and has held it in 2 quarters since.
56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.